RNA polymerase II degradation in response to rapamycin is not mediated through ubiquitylation

Nathalie Jouvet, Jeremie Poschmann, Julie Douville, Rim Marrakchi, Dindial Ramotar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

In Saccharomyces cerevisiae, the immunosuppressor rapamycin engenders the degradation of excessive RNA polymerase II leading to growth arrest but the regulation of this process is not known yet. Here, we show that this mechanism is dependent on the peptidyl prolyl cis/. trans isomerase Rrd1. Strikingly this degradation is independent of RNA polymerase II polyubiquitylation and does not require the elongation factor Elc1. Our data reveal that there are at least two alternative pathways to degrade RNA polymerase II that depend on different type of stresses.

Original languageEnglish
Pages (from-to)248-253
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume413
Issue number2
DOIs
Publication statusPublished - 23 Sept 2011
Externally publishedYes

Keywords

  • Peptidyl prolyl isomerase
  • RNA polymerase II degradation
  • Rapamycin
  • Rrd1
  • Ubiquitylation

Fingerprint

Dive into the research topics of 'RNA polymerase II degradation in response to rapamycin is not mediated through ubiquitylation'. Together they form a unique fingerprint.

Cite this